Puła, A.; Robak, P.; Mikulski, D.; Robak, T. The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. Int. J. Mol. Sci.2021, 22, 12070.
Puła, A.; Robak, P.; Mikulski, D.; Robak, T. The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. Int. J. Mol. Sci. 2021, 22, 12070.
Puła, A.; Robak, P.; Mikulski, D.; Robak, T. The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. Int. J. Mol. Sci.2021, 22, 12070.
Puła, A.; Robak, P.; Mikulski, D.; Robak, T. The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications. Int. J. Mol. Sci. 2021, 22, 12070.
Abstract
Multiple myeloma (MM) is a genetically complex disease that results from a multistep transformation of normal to malignant plasma cells in the bone marrow. However, the molecular mechanisms responsible for the initiation and heterogeneous evolution of MM remain largely unknown. A fundamental step needed to understand the oncogenesis of MM and its response to therapy is the identification of driver mutations. The introduction of gene expression profiling (GEP) in MM was an important step in elucidating the molecular heterogeneity of MM and its clinical relevance. Since some mutations in myeloma occur in non-coding regions, studies based on the analysis of mRNA provide more comprehensive information on the oncogenic pathways and mechanisms relevant to MM biology. In this review, we discuss the role of gene expression profiling in understanding the biology of multiple myeloma together with the clinical manifestation of the disease, as well as its impact on treatment decisions and future directions.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
